Gerbin Kaytlyn A, Yang Xiulan, Murry Charles E, Coulombe Kareen L K
Center for Cardiovascular Biology, University of Washington, Seattle, Washington, United States of America; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, United States of America; Department of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Center for Cardiovascular Biology, University of Washington, Seattle, Washington, United States of America; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
PLoS One. 2015 Jul 10;10(7):e0131446. doi: 10.1371/journal.pone.0131446. eCollection 2015.
Cardiac tissue engineering is a promising approach to provide large-scale tissues for transplantation to regenerate the heart after ischemic injury, however, integration with the host myocardium will be required to achieve electromechanical benefits. To test the ability of engineered heart tissues to electrically integrate with the host, 10 million human embryonic stem cell (hESC)-derived cardiomyocytes were used to form either scaffold-free tissue patches implanted on the epicardium or micro-tissue particles (~1000 cells/particle) delivered by intramyocardial injection into the left ventricular wall of the ischemia/reperfusion injured athymic rat heart. Results were compared to intramyocardial injection of 10 million dispersed hESC-cardiomyocytes. Graft size was not significantly different between treatment groups and correlated inversely with infarct size. After implantation on the epicardial surface, hESC-cardiac tissue patches were electromechanically active, but they beat slowly and were not electrically coupled to the host at 4 weeks based on ex vivo fluorescent imaging of their graft-autonomous GCaMP3 calcium reporter. Histologically, scar tissue physically separated the patch graft and host myocardium. In contrast, following intramyocardial injection of micro-tissue particles and suspended cardiomyocytes, 100% of the grafts detected by fluorescent GCaMP3 imaging were electrically coupled to the host heart at spontaneous rate and could follow host pacing up to a maximum of 300-390 beats per minute (5-6.5 Hz). Gap junctions between intramyocardial graft and host tissue were identified histologically. The extensive coupling and rapid response rate of the human myocardial grafts after intramyocardial delivery suggest electrophysiological adaptation of hESC-derived cardiomyocytes to the rat heart's pacemaking activity. These data support the use of the rat model for studying electromechanical integration of human cardiomyocytes, and they identify lack of electrical integration as a challenge to overcome in tissue engineered patches.
心脏组织工程是一种很有前景的方法,可为移植提供大规模组织,以在缺血性损伤后使心脏再生。然而,要实现机电方面的益处,还需要与宿主心肌整合。为了测试工程化心脏组织与宿主进行电整合的能力,使用了1000万个源自人类胚胎干细胞(hESC)的心肌细胞,来形成无支架组织贴片并植入心外膜,或形成微组织颗粒(约1000个细胞/颗粒),通过心肌内注射将其注入缺血/再灌注损伤的无胸腺大鼠心脏的左心室壁。将结果与心肌内注射1000万个分散的hESC心肌细胞进行比较。各治疗组之间的移植物大小无显著差异,且与梗死面积呈负相关。在心外膜表面植入后,hESC心脏组织贴片具有机电活性,但跳动缓慢,并且在4周时根据其移植物自主的GCaMP3钙报告基因的离体荧光成像显示,它们与宿主没有电耦合。组织学上,瘢痕组织在物理上分隔了贴片移植物和宿主心肌。相比之下,在心肌内注射微组织颗粒和悬浮心肌细胞后,通过荧光GCaMP3成像检测到的100%的移植物以自发速率与宿主心脏电耦合,并且能够跟随宿主起搏,最高可达每分钟300 - 390次搏动(5 - 6.5赫兹)。组织学鉴定了心肌内移植物与宿主组织之间的缝隙连接。心肌内递送后人类心肌移植物的广泛耦合和快速反应速率表明,hESC衍生的心肌细胞对大鼠心脏的起搏活动具有电生理适应性。这些数据支持使用大鼠模型来研究人类心肌细胞的机电整合,并且它们指出缺乏电整合是组织工程贴片需要克服的一个挑战。